Epigenetic modifications: Basic mechanisms and role in cardiovascular disease (2013 Grover Conference series)

Pulmonary Circulation

Volumn 4, Issue 2, 2014, Pages 169-174

  Loscalzo, Joseph ^a   Handy, Diane E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Histone; Homocysteine; Methylation; Noncoding RNAs; Pulmonary hypertension

Indexed keywords

EID: 85026338471     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1086/675979     Document Type: Review

References (52)

1. Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation 2011; 123:2145-2156.
2. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005;102:10604-10609.
3. Rakyan VK, Hildmann T, Novik KL, et al. DNA methyla-tion profiling of the human major histocompatibility complex: a pilot study for the Human Epigenome Project. PLoS Biol 2004;2:e405.
4. Abbott A. Project set to map marks on genome. Nature 2010;463:596-597.
5. Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet 2009;43:559-599.
6. Fedorova E, Zink D. Nuclear architecture and gene regulation. Biochim Biophys Acta 2008;1783:2174-2184.
7. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007;447:425-432.
8. Bird AP. CpG-rich islands and the function of DNA meth-ylation. Nature 1986;321:209-213.
9. Lister R, Pelizzola M, Dowen RH, et al. Human DNA meth-ylomes at base resolution show widespread epigenomic differences. Nature 2009;462:315-322.
10. Leonhardt H, Page AW, Weier HU, Bestor TH. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 1992;71:865-873.
11. Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011;145:423-434.
12. Tan L, Shi YG. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 2012;139:1895-1902.
13. Kouzarides T. Chromatin modifications and their function. Cell 2007;128:693-705.
14. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293:1074-1080.
15. Berndsen CE, Denu JM. Catalysis and substrate selection by histone/protein lysine acetyltransferases. Curr Opin Struct Biol 2008;18:682-689.
16. Mellert HS, McMahon SB. Biochemical pathways that regulate acetyltransferase and deacetylase activity in mammalian cells. Trends Biochem Sci 2009;34:571-578.
17. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007;404:1-13.
18. Metzger E, Wissmann M, Yin N, et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005;437:436-439.
19. Tsukada Y, Fang J, Erdjument-Bromage H, et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006;439:811-816.
20. Volkel P, Angrand PO. The control of histone lysine meth-ylation in epigenetic regulation. Biochimie 2007;89:1-20.
21. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009;10:155-159.
22. Schonrock N, Harvey RP, Mattick JS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res 2012;111:1349-1362.
23. Kim DH, Saetrom P, Snove O Jr., Rossi JJ. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci USA 2008;105:16230-16235.
24. Kim DH, Villeneuve LM, Morris KV, Rossi JJ. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol 2006;13:793-797.
25. Luteijn MJ, Ketting RF. PIWI-interacting RNAs: from generation to transgenerational epigenetics. Nat Rev Genet 2013;14:523-534.
26. He C. Grand challenge commentary: RNA epigenetics? Nat Chem Biol 2010;6:863-865.
27. Motorin Y, Helm M. RNA nucleotide methylation. Wiley Interdiscip Rev RNA 2011;2:611-631.
28. Ling C, Poulsen P, Simonsson S, et al. Genetic and epige-netic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J Clin Invest 2007;117:3427-3435.
29. Napoli C, Crudele V, Soricelli A, et al. Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms? Circulation 2012;125:2363-2373.
30. Painter RC, Roseboom TJ, Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 2005;20:345-352.
31. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000;275:29318-29323.
32. Ingrosso D, Cimmino A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003;361:1693-1699.
33. Jamaluddin MD, Chen I, Yang F, et al. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 2007;110:3648-3655.
34. Mikael LG, Genest J Jr., Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocystei-nemic mice and in males with coronary artery disease. Circ Res 2006;98:564-571.
35. Kim CS, Kim YR, Naqvi A, et al. Homocysteine promotes human endothelial cell dysfunction via site-specific epige-netic regulation of p66shc. Cardiovasc Res 2011;92:466-475.
36. Wang QT. Epigenetic regulation of cardiac development and function by polycomb group and trithorax group proteins. Dev Dyn 2012;241:1021-1033.
37. Zhou Y, Kim J, Yuan X, Braun T. Epigenetic modifications of stem cells: a paradigm for the control of cardiac progenitor cells. Circ Res 2011;109:1067-1081.
38. Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 2012;74: 13-40.
39. Archer SL, Marsboom G, Kim GH, et al. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation 2010;121: 2661-2671.
40. Kim GH, Ryan JJ, Archer SL. The role of redox signaling in epigenetics and cardiovascular disease. Antioxid Redox Signal 2013;18:1920-1936.
41. Zhao L, Chen CN, Hajji N, et al. Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid. Circulation 2012;126:455-467.
42. Cavasin MA, Demos-Davies K, Horn TR, et al. Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antipro-liferative mechanism. Circ Res 2012;110:739-748.
43. Bogaard HJ, Mizuno S, Hussaini AA, et al. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am J Respir Crit Care Med 2011;183:1402-1410.
44. Hohl M, Wagner M, Reill JC, et al. HDAC4 controls histone methylation in response to elevated cardiac load. J Clin Invest 2013;123:1359-1370.
45. Kao YH, Liou JP, Chung CC, et al. Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure. Int J Cardiol 2013;168:4178-4183.
46. Nallamshetty S, Chan SY, Loscalzo J. Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med 2013;64:20-30.
47. White K, Loscalzo J, Chan SY. Holding our breath: the emerging and anticipated roles of microRNA in pulmonary hypertension. Pulm Circ 2012;2:278-290.
48. Parikh VN, Jin RC, Rabello S, et al. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 2012;125:1520-1532.
49. Pullamsetti SS, Doebele C, Fischer A, et al. Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am J Respir Crit Care Med 2012;185:409-419.
50. Caruso P, Dempsie Y, Stevens HC, et al. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res 2012;111:290-300.
51. Courboulin A, Paulin R, Giguere NJ, et al. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 2011;208:535-548.
52. Kim J, Kang Y, Yojima Y, et al. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med 2013;19:74-82.